argenx SE | Investor Presentation Deck | 22 slides · page 16 of 22
The slide illustrates the neuromuscular junction mechanism and the clinical trial progression from healthy volunteers to patients with CMS and MuSK MG.
Conference presentation · other · present_solution · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 diagram 1/1 image 1/1 paragraph 1/1 title 1/1
Components 5
primary process illustration paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.